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Abstract
 .The interactions between iron and neuromelanin NM have been studied by means of EPR spectroscopy. The variable
temperature EPR spectral features of a specimen of NM extracted from normal human midbrains clearly indicate that iron is
 .present as polynuclear oxy-hydroxy ferric aggregates as well as isolated Fe III centres. Ferric oxy-hydroxy phases are
typical of the iron storage proteins ferritin and hemosiderin, but the comparison of the variable temperature EPR spectra of
 .ferritin and NM highlights significant differences between the two iron III oxy-hydroxy domains. Moreover, further
investigations on melanin models synthesised in the presence of either ferritin or a ferric salt as iron sources suggest that the
same pathway of formation and inclusion of the polynuclear iron oxide is operating in NM and in the model systems,
whatever is the source of iron.
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1. Introduction
Recent years have witnessed an increasing atten-
tion towards the cytotoxic activity of some by-prod-
w xucts of the oxidative metabolic pathways 1,2 . It is a
well accepted view that the exposition of cells and
tissues to highly reactive oxygen species such as
fly fl .O , OH , H O or singlet dioxygen may result,2 2 2
through lipid peroxidation chain reactions, in the
damage of cell membranes and, in turn, in cell death
 .oxidant stress . Cellular levels of these cytotoxic
species may be raised either by their increased pro-
duction or their incomplete clearance as well. Metal
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ions such as iron and copper can significantly con-
tribute to the production of toxic radicals through
w xFenton-like reactions 3 :
Fe II qH O “Fe III qOH flqOHy .  .2 2
thus enhancing the production of the very reactive
OH fl radical. The oxidant stress is also thought to be
 . w xat the onset of Parkinson’s disease PD 4–8 , a
disease consisting in the selective depletion of the
dopaminergic pigmented neurons of mesencephalic
 . w xSubstantia Nigra SN 9 . Support to this view has
been gained from histological and chemical analyses
of pathological SN tissues which revealed increased
levels of lipid peroxidation end-products, such as
malonyldialdehyde and hydroperoxides, and de-
creased levels of polyunsaturated fatty acids, the
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w xmain target of oxygen radicals in membranes 10,11 .
 .Reduced glutathione GSH levels also appear lower
in pathological tissues with respect to control ones
w x12–14 , suggesting a partial exhaustion of antioxi-
dant defences.
The oxidant stress in SN has often been related to
the observation that iron levels in this tissue and
neighbouring basal ganglia are quite higher than those
w xfound in other brain districts 14–19 . Thus, several
authors looked at a possible relationship between iron
content, distribution and valence state in SN and the
development of pathological states. There are several
claims about an increase of iron level in SN of
patients affected by PD with respect to control brains
w x7,14,20–26 . However, other studies did not show
w xany significant difference 18,19,27,28 . Attempts to
assess the distribution of iron in SN were performed
w xfirst by Hirsch et al. 29 by means of X-ray micro-
probe analysis technique. On comparing the intraneu-
ronal iron levels between NM containing districts and
regions devoid of NM, they found that, in control
brains, there were no significant differences between
the iron content in the presence or in the absence of
NM. Conversely, the investigations performed on SN
from patients with PD reported a significant increase
of the iron content in regions devoid of NM. By
w xmeans of the same technique, Jellinger et al. 30
obtained different results: they failed to observe de-
tectable iron signals in NM granules as well as in the
cytoplasm of control SN pars compacta, whereas high
Fe-peaks were detected in NM granules of SN pars
compacta from PD brains. Support to the view of an
increase of iron content in NM granules in PD brains
was gained by Good et al. by means of the laser
w xmicroprobe mass analyser. 31 . Moreover, it was
also found that ‘iron peaks in non-melanized neu-
ronal cytoplasm and adjacent neutropil were not sig-
nificantly different in PD patients and controls’. His-
tochemical assays indicated that in the cytoplasm of
SN dopaminergic neurons, either in PD and normal
brains, there is no appreciable amount of non-heme
w xiron compounds 32 . Finally, it is worth to recall that
caution must be used in comparing quantitative deter-
minations of iron obtained from techniques whose
sensitivity threshold depends on the chemical form of
the iron compound. Even more important, the above
summarised results can be somewhat dependent upon
the experimental work-up the biological samples had
undergone before the assay. Although these data
appear largely controversial, enough agreement exists
on the observation that in PD brains NM granules
accumulate iron. The low levels of NM-bound iron
w xobserved by Hirsch et al. 29 in PD SN may repre-
sent the situation encountered in the end stages of
degeneration of the dopaminergic neurons.
Uncertainties about the redox state of iron in con-
trol and pathological brains are also apparent. Some
 .  .papers report a decrease of the Fe II to Fe III ratio
w xin SN of PD patients 14,20,21 , but recent Mossbauer¨
 .spectroscopy studies clearly showed that Fe II can
not contribute to more than 5% of total iron in both
PD and control SN and no significant differences
were found between normal and pathological brains
w x  .27 . The appearance of high levels of iron II has
then been ascribed to artifacts possibly arising from
sample manipulation. Moreover, Mossbauer spec-¨
troscopy provided valuable insights into the chemical
binding state of iron in SN, since it clearly showed
that most of iron is present either in normal and
.parkinsonian SN as ferritin-like polynuclear aggre-
gates. From the available data about NM and SN iron
w xcontent 27,33–36 , it is evident that NM-bound iron
can account only to less than 15% of total SN iron,
the remaining iron species occurring mainly as fer-
ritin.
These observations clearly indicate that a better
understanding of the relationship between iron and
NM can not be obtained without getting rid of the
iron-containing compounds present in intact SN tis-
sues. Thus, the extraction of NM from SN tissues is
necessary in order to characterise its interaction with
iron.
The first attempt to characterise the iron domain in
purified NM is very recent. By means of Mossbauer¨
spectroscopy it has been shown that iron is present
essentially under the form of ferritin or hemosiderin
w xlike aggregates 36 . The close similarity between the
Mossbauer spectral pattern of purified NM and the¨
iron storage protein ferritin and its degradation prod-
.uct hemosiderin was taken as an indication that these
proteins could be themselves included within the NM
matrix, although no unambiguous evidence of the
inclusion of a proteic framework has been provided.
By means of Mossbauer Spectroscopy, NM-bound¨
iron levels were quoted to be as high as 2.8"1.4%
w x36 , this estimation being essentially in agreement
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with previous iron determinations obtained by radio-
 . w xchemical neutron activation analysis 3.08% 34 ,
 . w xatomic emission spectroscopy 1.50"0.18% 33
 . w xand total reflection X-ray fluorescence 0.92% 35 .
In order to get more insights into the characterisa-
tion of the iron domain in NM herein we report a
variable temperature EPR spectroscopy study of a
sample of NM extracted from SNs of patients died by
nonneurological diseases. The spectral features of this
sample have then been compared with those of syn-
thetic melanin models prepared in the presence of
different iron sources ferritin and pre-formed
.dopamine mononuclear chelates . As the primary aim
of this work is the assessment of the binding mode of
iron in NM, it has been useful to report analogous
EPR investigations carried out on samples of horse
spleen ferritin.
2. Materials and methods
2.1. Extraction of NM from SN tissues
The NM specimen was extracted from 9 mesen-
cephali of patients dying from nonneurological dis-
 .eases all males, mean age 59 years . SN pars com-
pacta specimens were excised during autopsy and
stored at y708C for 2–5 days; a pool of 2.2 g of
frozen tissue was obtained. The extraction of NM
was carried out following a procedure developed by
w x w xDas et al. 37 and modified as described in Ref. 33 .
Shortly, tissues were homogenised in phosphate buffer
 .0.05M pHs6.5 and washed twice with the same
buffer. The solid matter was collected by centrifuga-
tion and treated with a chloroformrmethanol 2:1
mixture to remove the lipidic fractions. The organic
solvents were then removed by washings with
methanol and phosphate buffer. The solid residue was
incubated for 30 min in a 0.3% saponin solution
containing 0.9% NaCl and, after centrifugation, the
sample was washed 3 times with a 5 mM MgCl and2
0.15% NaCl solution. The specimen was then submit-
ted to a proteolytic treatment, carried out by incuba-
 .tion with 2 mgrml of Pronase E EC 3.4.24.4 and
 .0.5% SDS in 0.05 M Tris buffer pHs8.0 , for 48 h
at 378C. After final washings with phosphate buffer
the solid residue was dialysed for two days against
the same buffer. It was then suspended for 12 h in 2
ml of 10 mM DTPA solution followed by two more
washings with phosphate buffer and dried in vacuo.
This work-up allowed about 5 mg of dry NM to be
recovered. Particular care was devoted to the choice
of iron-free tools, reagents and glassware during all
the extraction and purification steps in order to avoid
metal contamination of the sample. Reagents were
purchased from Sigma-Aldrich and were of the high-
est degree of purity available.
2.2. Synthesis of NM models
NM models were synthesised by enzymatic
 .  .tyrosinase oxidation of dopamine DA in the pres-
ence of different iron containing compounds. Tyrosi-
nase was purchased from Fluka, whereas horse spleen
ferritin highly purified, freeze-dried, 15% iron con-
.tent by weight was supplied by Zanoni Pharmaceuti-
 .cals Santhia, Italy ; all the other reagents were pur-`
chased from Sigma-Aldrich.
2.2.1. Horse spleen ferritin based model
1.15 g of DA were dissolved in 800 ml of 20 mM
 .phosphate buffer pHs6.8 containing 20 mg of
 .reduced glutathione GSH , 4 U glutathione peroxi-
 .dase EC 1.11.1.9, 170 Urmg as a scavenger of
H O produced by the enzymatic oxidation of DA,2 2
50 mg of cysteine, and 160 mg of ferritin corre-
.sponding to 0.43 mmol Fe . Then 10 mg of mush-
 .room tyrosinase EC 1.14.18.1, 172 Urmg were
added. The reaction mixture was incubated for 36 h
at 378C and then cooled to 48C for 12 h in order to
promote the aggregation of the polymer units. The
dark precipitate was collected by centrifugation,
washed twice with aliquots of 40 ml of 20 mM
phosphate buffer, suspended in 40 ml of a phosphate
 .buffer 20 mM, pHs7.0 solution containing 20 mM
DTPA, incubated for 24 h and, finally, washed twice
again with phosphate buffer. A final washing of the
black solid was carried out with acetone, and the
recovered solid material was allowed to dry at the air.
This procedure yielded 290 mg of dried melanin
containing 3% of iron by weight, as determined by
atomic absorption spectroscopy.
( )2.2.2. Iron III salt based model
In the synthesis of this model special care has been
devoted to avoid that the formation of oxy-hydroxy
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ferric particles preceded the formation of the melanin
 .macromolecule. 20 ml of an acidic solution pHs2
containing 1.15 g of DA were added to 20 ml of a
 . solution containing 170 mg of Fe NO P9H O cor-3 3 2
.responding to 0.42 mmol Fe . The pH of the resulting
solution was gradually increased by slow addition of
 .20 mM phosphate buffer pHs6.8 until a final
volume of 800 ml was reached. While maintaining
the pH of 6.8, the other reagents were added in the
same amounts as for the ferritin-based model and the
incubation started. In this way, the presence of iron
 .DA complexes DA is in large excess should prevent
the rapid polymerisation to iron oxides. The time of
incubation and the work-up for melanin recovery
were the same as described above. This procedure
yielded 260 mg of dried melanin containing 2% iron,
as determined by atomic absorption spectroscopy.
2.3. EPR measurements
EPR spectra were recorded with a X-band Varian
E-109 spectrometer equipped with a Stelar interface
and Stelar 961.0 program for digital acquisition. Var-
 .ian Pitch gs2.0028 was used for g values calibra-
tion.
Samples were loaded in 4 mm diameter iron free
quartz EPR tubes. Before recording the spectra, sam-
 y3 .ples were degassed at RT P-10 torr .
3. Results and discussion
3.1. EPR features of Fe3q
 5.Ferric ions 3d are easily observed by EPR in
particular in the very common high spin configura-
tion. The interpretation of the spectra of Fe3q is
however not straightforward due to the high number
of parameters that determine the spectrum itself. High
spin Fe3q is a Ss5r2 ion with a 6S ground state
whose spin transitions depend on both the electron
 .Zeeman interaction and the zero field splitting ZFS .
The latter interaction is, in turn, determined by the
57  .two parameters D and E. The effect of Fe Is1r2
is negligible due to the low abundance of this isotope.
The spin Hamiltonian operator for Fe3q can be thus
written down, at the second order approximation, as
follows:
12 2 2Hˆsm BgSqD S y S Sq1 qE S yS .B z x y3
where B is the external magnetic field, S is the spin
vector with S , S and S components, Ss5r is thex y z 2
spin quantum number of Fe3q and m is the BohrB
magneton. The features of the spectrum are basically
determined by the extent of ZFS which reflects the
deviation of the ion crystal field from ideal tetrahe-
dral or octahedral symmetry for which DsEs0.
When the reduced symmetry is axial D/0 and
Es0, while both values differ from zero for non-axial
 .symmetries. In the case of no or very small ZFS the
energy of the microwave is higher than D g m BB 0
.4D and the allowed transition energies correspond
to a g value around 2.0. In the opposite and quite
 .common case D4g m B the spectral features areB 0
much more complex even though only a part of the
whole set of transitions can be observed at the operat-
 .ing frequency of the X-band 9.5 GHz ; the observed
transitions are thus usually labelled by a fictitious
 .  .  .value of g g , being g s hn r m B , whereeff eff B res
B is the resonant magnetic field.res
3.2. EPR spectroscopy of NM
The variable temperature EPR spectra of the NM
specimen are reported in Fig. 1. Before recording the
EPR spectra, this specimen has been washed with a
solution of DTPA in order to remove weakly bound
iron.
The EPR spectrum recorded at room temperature
 .Fig. 1, bottom trace consists of a broad absorption
 .centred at g s2.1 signal labelled B . Upon vary-eff
ing the temperature a number of spectral changes are
observed:
 .i A resonance line appears at g s4.3 whoseeff
intensity increases with decreasing temperature.
 .ii The broad signal observed in the room temper-
ature spectrum at g s2.1 shows to be due to theeff
overlap of two components; one of these components
 Y.signal B sharpens up significantly when the tem-
perature is decreased to 120 K its peak-to-peak
linewidth drops out from ca. 500 G at 157 K to ca.
. Y250 G at 120 K . The B component further looses
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Fig. 1. Variable temperature EPR spectra of neuromelanin ex-
tracted from human midbrain of patients died by nonneurological
diseases. All the spectra were recorded with the following instru-
mental settings: microwave frequency 9.4 GHz; modulation fre-
quency 100 KHz; microwave power 10 mW; modulation ampli-
tude 4 Gauss; time constant 0.128 s; scan time 4 min; scan range
10000 Gauss.
intensity at T-120 K and eventually disappears at
T-100 K. The second component at lower field
 X.signal B is very broad and is best observed in the
spectrum at 4 K; moreover, it shows a shift towards a
limiting g value of ca 2.6 at 4 K.eff
 .  .iii A sharp signal at gs2.0 signal C becomes
detectable in the low temperature spectra.
 .The latter resonance signal C is easily assigned
w xto the melanin organic radical 49–51 whereas the
signal at g s4.3 is typical of high spin ferric ionseff
at sites endowed with rhombic symmetry. Both gs
2.0 and g s4.3 absorptions display the expectedeff
Curie behaviour upon decrease in temperature
whereas the BX and BY broad absorptions share an
antiferromagnetic-like behaviour. On the basis of the
much higher content in iron of NM with respect to
w xany other paramagnetic metal ion 29,31,33–36 , we
conclude that BX and BY resonances have to be
assigned to iron-containing systems. Broad absorp-
tions such as BX and BY signals with an analogous
temperature behaviour are rather common in inor-
ganic iron containing systems and, for instance, they
have been discussed in detail for Fe-zeolites and
w xFe-silicalite systems 38–41 . This kind of absorp-
tions is commonly assigned to tiny, variously hy-
drated iron-oxide aggregates. Their behaviour upon
changes in temperature indicates that the metal ions
are organised in superparamagnetic or antiferromag-
netic domains. This conclusion appears to be consis-
tent with recent results obtained by Mossbauer spec-¨
w xtroscopy 36 pointing to the occurrence of ferritin or
 .hemosiderin-like polynuclear aggregates of iron III
oxides in NM.
 .In order to assess whether the polynuclear iron III
oxide in NM is the result of the inclusion of ferritin
or hemosiderin in the neuromelanin framework we
undertook a detailed variable temperature EPR study
of ferritin itself.
3.3. EPR in˝estigations on ferritin
Ferritin is the major iron storage cellular system in
mammals; it is a complex protein resulting by the
aggregation of 24 subunits to give a hollow sphere
which can store inside up to 4500 iron atoms in form
of a complex mixture of ferric hydroxide and ferric
 .  . w xphosphate FeOOH FeO-OPO H 42,43 in which8 3 2
iron is coordinated in a fairly regular octahedral
pattern. The maximum size of the inorganic core is
ruled by the dimension of the interior cavity of
˚ .ferritin about 70 A , the diameter of the whole
˚structure being about 100–110 A. Actually, this inor-
ganic core may show some variability in its composi-
tion and structure depending on the biological origin
w xand on loadingrunloading conditions 44 .
The EPR spectra of several samples of freeze-dried
horse spleen ferritin, whose iron content ranged from
2% to 15% by weight, have been recorded. No
substantial difference has been noticed in their spec-
tral patterns at room temperature. As shown in Fig. 2,
the EPR spectrum of ferritin consists of two main
signals due to iron ions of the ferrihydrite core the
first at g s2.0 with a peak-to-peak linewidth of ca.eff
1100 G and the second one appearing as an even
.broader, poorly resolved shoulder at lower field in
addition to a small absorption due to rhombohedric
 .Fe III sites at g s4.3. These observations areeff
w xconsistent with those reported by others 45,46 on
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Fig. 2. Variable temperature EPR spectra of horse spleen ferritin
containing 15% iron by weight. All the spectra were recorded
with the following instrumental settings: microwave frequency
9.4 GHz; modulation frequency 100 KHz; microwave power 10
mW; modulation amplitude 4 Gauss; time constant 0.128 s; scan
time 4 min; scan range 10000 G.
frozen solutions of ferritin or frozen suspensions of
hemosiderin. As the temperature is decreased, the
two absorptions are better distinguished, but not com-
pletely resolved on our X-band EPR spectrometer.
The observed changes with the temperature are rather
smooth and there is no evidence of the abrupt varia-
tion detected in the corresponding spectra of NM on
 .going from 157 K to 120 K see Fig. 1 .
On the basis of the comparison between the sets of
variable temperature EPR spectra of NM and ferritin,
we conclude that the structure of the iron core in NM
is not exactly the same one found in ferritin.
3.4. EPR in˝estigations on model systems
We considered two synthetic models differing in
 .the form by which iron III is supplied. In model A,
the source of iron was horse spleen ferritin whereas
in model B a mononuclear chelate complex between
 .Fe III ions and dopamine was first formed. In both
cases, the melanogenesis was enzymatically catalysed
by tyrosinase and the starting material was dopamine.
Cysteine and GSH were also present in the reaction
mixture. Besides to provide an environment more
similar to that in which melanogenesis is likely to
occur in living systems, GSH and cysteine act as
 .reducing agents for Fe III in ferritin and allow its
out-come from the protein interior cavity. It is likely
that ferritin releases iron gradually, thus making
available a continuous flow of iron ions as the
melanogenesis proceeds. In the case of model B
ferric nitrate was used as the iron source; however, in
order to ensure the availability of iron ions under the
form of mononuclear, soluble complexes, they have
 .been first complexed with DA see Section 2 . In this
form, all the iron ions are available to the reaction
environment since the very beginning of the melano-
genetic process. The content of iron in the two mod-
els after washings with excess of DTPA about 3%
.and 2% for models A and B, respectively , was not
w xtoo far from that found in the native NM 33 treated
with the chelating agent in a similar way. As shown
in Fig. 3, the EPR spectra of the two models recorded
at room temperature were quite similar. Both show
the sharp signal of melanin free radicals at gs2.0,
more intense than in the native NM, and the signal at
 .g s4.3 due to rhombohedric Fe III sites. Also thiseff
Fig. 3. EPR spectra recorded of dopamine melanin models syn-
thesized enzymatically in the presence of different iron sources:
 .  .A model from horse spleen ferritin; B model from inorganic
ferric nitrate. Instrumental settings: microwave frequency 9.4
GHz; modulation frequency 100 KHz; microwave power 10 mW;
modulation amplitude 4 Gauss; time constant 0.128 s; scan time 4
min; scan range 10 000 G.
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signal is more intense than in the native pigment and
it is taken as an indication of an improved ability of
the synthetic melanin to act as a ion-exchange resin.
Moreover, a noticeable part of the iron contributes to
the broad resonance characterised at room tempera-
ture by a g value of 2.1–2.3 due to polynucleareff
 .oxy-hydroxy Fe III arrays. Superparamagnetic iron-
oxide phases directly bound to melanins have also
been observed in iron-loaded synthetic and natural
w xmelanins 47 . It was also shown that the mean
particle size and, therefore, the magnetic behaviour of
these particles were dependent upon the nature of the
melanin precursors. Since we detected appreciable
amounts of mononuclear iron sites in addition to
polynuclear ones, it is likely that other reaction pa-
rameters can affect the mode of iron binding. It
should be noted that the occurrence of at least two
binding modes for iron have also been claimed by
w xother groups 47,48 . The different population ratio
between the mononuclear and polynuclear binding
modes found in NM with respect to the synthetic
models can therefore be accounted for in terms of the
differences in the melanogenetic rate and in the bio-
chemical environment occurring in vivo and in vitro.
Thus, whenever iron is supplied in the form of
pre-organised oxy-hydroxy polymer ferritin, model
. A or in the form of a mononuclear complex model
.B , both systems afford an iron subdomain whose
polymeric structure is very similar to that found in
the native NM. It is then apparent that, once in
 .solution, iron III precipitation is prevented by com-
plex formation with catechols, melanochromes
andror related coordinating systems. These com-
plexes can be included as such in the growing poly-
mer or they can nucleate into oxy-hydroxy particles.
One may envisage a process through which, as the
melanogenesis proceeds, a catecholic ligand may dis-
sociate from the complex leaving free coordination
positions at the metallic ion which, according to the
well-known schemes of iron aqueous chemistry, may
act as a nucleation centre for iron oxide polymerisa-
tion. These processes likely result in an irregular
 .distribution of oxy-hydroxy Fe III oligomers tightly
bound to the melanin. The deep embedding of iron
within the polymer is consistent with the observation
that most of iron cannot be extracted by prolonged
treatment of the re-suspended melanins with strong
chelating agents.
4. Discussion
As we stated in the introductory section, a detailed
understanding of the relationships between iron and
NM can provide a relevant etiologic clue to PD. We
also emphasised that, due to the presence of high
levels of iron in SN, the characterisation of the
interaction between iron and NM can not be carried
out without extracting the pigment from the whole
tissue. However, the purification procedure can lead,
in principle, to artifacts in the NM-iron binding state.
In fact, iron could be lost, added or modified in its
binding mode during the purification work-up. Actu-
ally, some observations dealing with the changes
occurring in the metal binding mode to NM during
the purification procedure of NM have already been
w xreported by Enochs et al. 51 by means of EPR
spectroscopy. Their considerations were based on the
fact that the intensity of the melanin organic radical
 .signal gs2.0 is heavily quenched by the binding
 .of paramagnetic metal ions, such as Fe III , as a
result of dipole-dipole magnetic interactions between
the transition metal ion and the organic radical elec-
w xtronic spins 50 . The observation that the intensity of
the melanin radical signal depends upon iron binding
to the melanin therefore provides a sensitive probe
for following changes in the metal binding mode to
w xNM and its synthetic models. Enochs et al. 51 noted
that in unprocessed SN, the EPR free radical signal
was low but still detectable, and that it could be
recovered and highly magnified as the paramagnetic
ions were displaced from the melanin framework by
means of a harsh acidic attack. This is a clear evi-
dence that NM must be associated with a large
amount of metals, hence iron, in unprocessed SN.
w xZecca et al. 49 investigated the effectiveness of
chelators to remove iron ions from the melanin
framework and found that, upon treatment with EDTA
of a sample of homogenated SN, the melanin radical
signal gs2.0 significantly increased with respect to
the signal found in unprocessed SN. Moreover, also
in the case of extracted NM, they noted an increase in
the intensity of this EPR signal upon treatment with
EDTA. Thus the sequestering of metal ions by EDTA
yields the same effect in the EPR spectrum of the
unprocessed SN or in the one of the purified NM.
Remarkably, despite the treatment with the strong
chelator, the iron content of this NM specimen was
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 .rather high about 0.9% . This finding is in agree-
ment with the results obtained in other works, in
which it is reported that NM specimens suspended in
solution of strong chelators were found to maintain
 w xan high iron content 1.50"0.18% 33 , 2.8"1.4%
w x.36 . These observations are consistent with the view
that, although NM can collect iron from other cellular
or tissutal districts during the extraction procedure,
this extra-iron can be removed by chelation treatment
 .‘exchangeable iron’ . However, in NM there is an
additional iron pool which appears not to be removed
by chelators. Despite the definition of ‘exchangeable
iron’, we can not determine the amount of this type
of iron already present in the native pigment but it is
possible to establish which is the main binding mode
of such extra-iron. In fact, it has been shown that,
when an essentially iron-free synthetic melanin is
added to a non-melanised brain tissue homogenate,
accumulation of iron at the NM granules takes place
w x49 . This happens because synthetic melanins bear a
large number of potential binding sites and then it
acts as a ion-exchange resin for iron ions. The ab-
sorption of iron from tissue homogenate was shown
to contribute essentially to the signal at g s4.3 ineff
w xthe EPR spectrum 49 . Thus, extra-iron ions are
mainly bound as isolated centres.
In summary, although we are unable to assess to
what extent an eventual contamination of our sample
has occurred during the purification procedure, we
think that the treatment of the NM specimen with a
strong chelator like DTPA ensures us that we are
dealing with a system which is a reliable reporter of
the in vivo situation, at least as far as the more
strongly bound iron ions are concerned.
The EPR spectra of purified NM reported in this
paper showed the existence of two distinct pools of
 .Fe III ions, associated with EPR signals at g s4.3eff
and g s2.1–2.3 respectively. On the basis of theeff
 .above discussion, the former iron III pool is the one
which can be more likely affected by artifacts resid-
.ual ‘exchangeable iron’ . Although the areas of EPR
signals can not be simply related to concentrations,
this pool seems to be significantly less populated than
the polynuclear one see, for comparison, the EPR
.spectra of models reported in Fig. 3 . Thus, the
VT-EPR spectra of NM strongly indicate that iron is
peculiarly organised in NM as polynuclear oxy-hy-
droxy aggregates showing a superparamagnetic be-
haviour. This result is consistent with that found by
w xGerlach et al. by Mossbauer spectroscopy 36 . These¨
authors also found a close similarity between the
spectral behaviour of human NM with that of the iron
storage proteins ferritin and hemosiderin, so that they
proposed the occurrence of these proteins tightly
associated with the proper melanin framework. On
the other hand, on comparing the VT-EPR spectra of
NM and ferritin, we found that some differences
between the inorganic polymeric core of NM and the
ferritin one do exist.
Model studies have provided a route to get more
insight into the understanding of such differences. All
the models herein considered contained at least two
populations of iron sites in melanins, due to small
 .iron oxy-hydroxy aggregates and to isolated Fe III
ions respectively. Hence, all the models showed that
at least a fraction of melanin-bound iron had a struc-
tural set-up similar to that of NM EPR signals at
.g s2.1–2.3 , irrespective of the compound used aseff
the source of iron. This observation strongly suggests
that melanins can drive the nucleation of polynuclear
oxy-hydroxy phases directly bound to the melanin
functionalities. Thus, although in principle the inclu-
sion of ferritin as such in the melanin framework is
possible for instance, through the formation of cova-
.lent bonds between the protein and the melanin ,
there is no need to invoke the inclusion of the iron
storage protein in the neuromelanin framework in
order to explain the presence of iron oxy-hydroxy
phases. In this view, the iron oxy-hydroxy polymer in
NM is likely to be smaller and less regular than the
one growing up in the template cavity of ferritin. The
interaction between the oxy-hydroxy iron polymer
with the surrounding substrate should be quite differ-
ent in the two compounds, since it is characterised by
hydrogen bonds with amide moieties and aminoacidic
residues in the case of ferritin, and catecholic or
quinonic moieties in the case of melanin. The close
similarity found in the EPR spectra of NM and
models on one side, and in Fe-silicalite systems on
the other side, points to suggest the occurrence of
small-sized iron oligomers compatible with the di-
mensions of the silicalites cavities. Furthermore, the
interaction between the iron containing polymer and
the surroundings in NM may be even more complex
since its 13C-CPMAS NMR spectrum suggested the
additional involvement of a glyco-lipidic matrix
( )S. Aime et al.rBiochimica et Biophysica Acta 1361 1997 49–58 57
which, in turn, is thought to contribute to the overall
w xinsolubilisation of the iron pool 33 .
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